Discussion Compared to usual care , the use of telemedicine was found to improve HbA1c and reduce the risk of moderate hypoglycaemia  in diabetic patients , but without significant difference in BMI
Introduction Hypoglycaemia is a clinical syndrome from various causes , which happens when the blood glucose concentration is too low .
Many studies show that telemedicine intervention can improve glycemic control and has a positive impact on the management of diabetic patients .
The purpose of this study was to evaluate the effect of telemedicine intervention on hypoglycemic event occurrences and results on hemoglobin A1c ( HbA1c ) and body mass index ( BMI ) .
Glycemic control after hospital discharge in insulin-treated type 2 diabetes: a randomized pilot study of daily remote glucose monitoring.
OBJECTIVE Little is known about glycemic control in type 2 diabetes patients treated with insulin in the high-risk period between hospital discharge and follow-up . We sought to assess the impact of remote glucose monitoring on postdischarge glycemic control and insulin titration . METHODS We r and omly assigned 28 hospitalized type 2 diabetes patients who were discharged home on insulin therapy to routine specialty care ( RSC ) or RSC with daily remote glucose monitoring ( RGM ) .  We compared the primary outcome of mean blood glucose and exploratory outcomes of hypoglycemia/hyperglycemia rates , change in hemoglobin A1c and glycated albumin , and insulin titration frequency between groups . RESULTS Mean blood glucose was not significantly different between the treatment arms ( 144 ± 34 mg/dL in the RSC group and 172 ± 41 mg/dL in the RGM group ; not significant ) , nor were there significant differences in any of the other measures of glycemia during the month after discharge . Hypoglycemia ( glucometer reading < 60 mg/dL ) was common , occurring in 46 % of subjects , with no difference between groups . In as-treated analysis , insulin dose adjustments ( 29 % with an increase and 43 % with decrease in insulin dose ) occurred more frequently in the patients who used RGM ( average of 2.8 vs. 1.2 dose adjustments ; P = .03 ) . CONCLUSION In this pilot trial in insulin-treated type 2 diabetes , RGM did not affect glycemic control after hospital discharge ; however , the high rate of hypoglycemia in the postdischarge transition period and the higher frequency of insulin titration in patients who used RGM suggest a safety role for such monitoring in the transition from hospital to home
Discussion Compared to usual care , the use of telemedicine was found to improve HbA1c and reduce the risk of moderate hypoglycaemia  in diabetic patients , but without significant difference in BMI
Introduction Hypoglycaemia is a clinical syndrome from various causes , which happens when the blood glucose concentration is too low .
Many studies show that telemedicine intervention can improve glycemic control and has a positive impact on the management of diabetic patients .
The purpose of this study was to evaluate the effect of telemedicine intervention on hypoglycemic event occurrences and results on hemoglobin A1c ( HbA1c ) and body mass index ( BMI ) .